Shares in Eli Lilly shot up last Thursday after the US pharma major announced positive top-line Phase III results from ...

A new report highlights disparities in access to CAR T-cell therapies across Europe, with eligible patient treatment rates as ...

Denmark-based allergy immunotherapy specialist ALK Abello (ALKB. DC) today announced that its Itulazax (tree pollen ...

Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...

The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to ...

Autoimmune diseases specialist Immunovant has announced changes to its leadership team and the expanded development of its ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

French drug developer Innate Pharma’s (Euronext Paris: IPH) shares were up 5.6% at 1.81 euros in early trading after it ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...

Cambridge, USA-based biotech Repertoire Immune Medicines today announced a collaboration and license agreement with Genentech ...

The Russian pharma trade group Innovative Pharma (Inpharma) has sent an official letter to the Ministry of Industry and Trade ...

German family-owned pharma major Boehringer Ingelheim and Dutch precision oncology company Tessellate Bio have entered into a ...